IXICO plc (PHYOF)

Market Cap	11.09M
Revenue (ttm)	7.73M
Net Income (ttm)	-2.68M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	3,392
Open	0.0700
Previous Close	0.1500
Day's Range	0.0700 - 0.0700
52-Week Range	0.0700 - 0.1500
Beta	0.69
RSI	43.74
Earnings Date	May 20, 2025

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 81
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHYOF

Financial Performance

In 2024, IXICO's revenue was 5.77 million, a decrease of -13.49% compared to the previous year's 6.67 million. Losses were -2.00 million, 69.9% more than in 2023.

Financial numbers in GBP